Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
NCT06524882 · View on ClinicalTrials.gov ↗
Study Summary
Participants eligible for the study will be randomly allocated (1:1:1) to receive either Luminopia dichoptic treatment while wearing optical correction if needed, Vivid Vision dichoptic treatment while wearing optical correction if needed, or continued optical correction alone if needed, with clinical assessments at 9- and 18-weeks post-randomization. At the 18-week primary outcome visit, participants who were randomly assigned to receive optical correction alone if needed with an IOD of 1 logMAR line (5 letters) or more, will be offered randomization to Luminopia or Vivid Vision dichoptic therapy and if they accept, followed forward with visits at 27- and 36-weeks post-randomization. The study will end for all other participants at 18 weeks.
Conditions Studied
Interventions
- DEVICE Luminopia
- DEVICE Vivid Vision
- DEVICE Optical Correction
Study Locations (20)
California
- University Eye Center at Ketchum Health — Anaheim
- Univ. of California- Berkeley — Berkeley
- Univ of California, Irvine- Gavin Herbert Eye Institute — Irvine
- Stanford University — Palo Alto
- Western University College of Optometry — Pomona
- University of California, Davis — Sacramento
- University of California San Francisco Department of Ophthalmology — San Francisco
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago
- Illinois College of Optometry — Chicago
- Midwestern University Eye Institute — Downers Grove
- Progressive Eye Care — Lisle
Arizona
- Midwestern University Eye Institute — Glendale
- Phoenix Children's Medical Group - Ophthalmology — Scottsdale
- University of Arizona — Tucson
Arkansas
- Arkansas Childrens — Little Rock
- McFarland Eye Care Center — Little Rock
Florida
- Nova Southeastern University College of Optometry, The Eye Institute — Fort Lauderdale
- University of South Florida (USF) Eye — Tampa
Alabama
- UAB Pediatric Eye Care; Birmingham Health Care — Birmingham
Indiana
- Indiana School of Optometry — Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2024-10-22 |
| Est. Completion | 2027-11-01 |
| Phase | Phase 3 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06524882
The ClinicalTrials.gov registry entry for NCT06524882 describes a study currently listed as recruiting. It is categorized as Phase 3, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 134 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Amblyopia appearing as the primary indexed condition, and to 3 interventions — of which Luminopia is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06524882 reports 20 study locations spanning 7 distinct geographic areas — top geographies include California, Illinois, Arizona. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06524882 about?
NCT06524882 is a clinical study titled "Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age". Participants eligible for the study will be randomly allocated (1:1:1) to receive either Luminopia dichoptic treatment while wearing optical correction if needed, Vivid Vision dichoptic treatment while wearing optical correction if needed, or continued optical correction alone if needed, with clinic...
What is the current status of trial NCT06524882?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 252 participants. The study started on 2024-10-22. Estimated completion is 2027-11-01.
What conditions does trial NCT06524882 study?
This clinical trial studies the following conditions: Amblyopia. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06524882?
The interventions under investigation include: Luminopia (DEVICE), Vivid Vision (DEVICE), Optical Correction (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06524882?
This trial is sponsored by Jaeb Center for Health Research, which has 134 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06524882 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.